CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 45 filers reported holding CYTOSORBENTS CORP in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 22 | -99.8% | 0.00% | – |
| Q4 2020 | $94,000 | +77.4% | 11,792 | +11.0% | 0.00% | – |
| Q3 2019 | $53,000 | -49.0% | 10,620 | -32.6% | 0.00% | – |
| Q2 2019 | $104,000 | +6.1% | 15,751 | +13.6% | 0.00% | – |
| Q1 2018 | $98,000 | -37.6% | 13,868 | -42.6% | 0.00% | – |
| Q4 2017 | $157,000 | +57.0% | 24,148 | -5.4% | 0.00% | – |
| Q1 2016 | $100,000 | +23.5% | 25,527 | +75.4% | 0.00% | – |
| Q4 2015 | $81,000 | – | 14,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |